液态切片全球市场2024-2028

2023-2028 年液态切片市场价值预估为 36.964 亿美元，预测期内复合年增长率为 25.2%。

该报告包括对液态切片市场的总体分析、市场规模/预测、趋势、成长驱动因素、挑战以及涵盖约 25 家供应商的供应商分析。

它提供了对当前市场状况、最新趋势和驱动因素以及整体市场环境的最新分析。该市场的驱动因素包括癌症发病率的增加、癌症治疗中个人化医疗的日益关注以及液态切片技术的进步。

研究指出，液态切片领域资金/投资的增加是未来几年推动液态切片市场成长的关键因素之一。此外，学术机构、产业、併购和液态切片的新兴应用之间的策略合作伙伴关係带来了巨大的市场需求。

目录

第一章执行摘要

• 市场概况

第二章 市场状况

• 市场生态系统
• 市场特征
• 价值链分析

第三章 市场规模评估

• 市场定义
• 细分市场分析
• 2023 年市场规模
• 2023-2028年市场展望

第四章 市场规模表现

• 全球液态切片市场 2018-2022
• 2018-2022 年按应用分類的细分市场分析
• 2018-2022 年按技术分類的细分市场分析
• 2018-2022 年区域細項分析
• 2018-2022 年国家細項分析

第五章五力分析

• 五力摘要
• 买方议价能力
• 供应商的议价能力
• 新进入者的威胁
• 替代品的威胁
• 竞争威胁
• 市场状况

第六章市场细分：按应用

• 市场区隔
• 比较：按应用
• 癌症应用：2023-2028 年市场规模与预测
• 非癌症应用：2023-2028 年市场规模与预测
• 市场机会：依应用分类

第七章市场细分：依技术

• 市场区隔
• 比较：按技术
• CTC 和 ctDNA：2023-2028 年市场规模与预测
• 胞外体和 RNA：2023-2028 年市场规模和预测
• 市场机会：依技术分类

第八章 客户状况

• 客户状况概览

第九章 地区情势

• 区域细分
• 区域比较
• 北美：2023-2028 年市场规模与预测
• 欧洲：2023-2028 年市场规模与预测
• 亚洲：2023-2028年市场规模与预测
• 世界其他地区：2023-2028 年市场规模与预测
• 美国：2023-2028 年市场规模与预测
• 加拿大：2023-2028 年市场规模与预测
• 德国：2023-2028年市场规模与预测
• 英国：2023-2028 年市场规模与预测
• 日本：2023-2028年市场规模与预测
• 市场机会：依地区状况

第十章 促进因素、挑战、机会、限制因素

• 市场驱动因素
• 市场挑战
• 驱动因素和挑战的影响
• 市场机会与限制

第十一章竞争格局

• 概述
• 竞争格局
• 混乱的情况
• 产业风险

第十二章 竞争分析

• 公司简介
• 公司市场定位
• A. Menarini Industrie Farmaceutiche Riunite Srl
• ANGLE Plc
• Bio Techne Corp.
• Biocept Inc.
• Biodesix Inc.
• CellMax Inc.
• CIRCULOGENE
• Exact Sciences Corp.
• F. Hoffmann La Roche Ltd.
• Guardant Health Inc.
• Illumina Inc.
• MDXHEALTH SA
• Myriad Genetics Inc.
• QIAGEN NV
• SAGA Diagnostics AB

第十三章附录

The liquid biopsy market is forecasted to grow by USD 3696.4 mn during 2023-2028, accelerating at a CAGR of 25.2% during the forecast period. The report on the liquid biopsy market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by increasing incidence of cancer, growing focus on personalized medicine for cancer care, and advancements in liquid biopsy technologies.

Technavio's liquid biopsy market is segmented as below:

ByApplication

• Cancer applications
• Non-cancer applications

ByTechnology

• CTC and ctDNA
• Exosome and RNA

ByGeography

• North America
• Europe
• Asia
• Rest of World (ROW)

This study identifies the increasing funding/investment for liquid biopsy as one of the prime reasons driving the liquid biopsy market growth during the next few years. Also, strategic partnerships among academic institutions, industries and M and A and emerging applications of liquid biopsy will lead to sizable demand in the market.

The report on the liquid biopsy market covers the following areas:

• Liquid biopsy market sizing
• Liquid biopsy market forecast
• Liquid biopsy market industry analysis

The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading liquid biopsy market vendors that include A. Menarini Industrie Farmaceutiche Riunite Srl, ANGLE Plc, Bio Rad Laboratories Inc., Bio Techne Corp., Biocept Inc., Biodesix Inc., CellMax Inc., CIRCULOGENE, Exact Sciences Corp., F. Hoffmann La Roche Ltd., Guardant Health Inc., Illumina Inc., Inivata Ltd., MDXHEALTH SA, Mesa Laboratories Inc., Myriad Genetics Inc., Novogene Co. Ltd., OncoCyte Corp., QIAGEN NV, and SAGA Diagnostics AB. Also, the liquid biopsy market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.

Table of Contents

1 Executive Summary

• 1.1 Market overview
  • Executive Summary - Chart on Market Overview
  • Executive Summary - Data Table on Market Overview
  • Executive Summary - Chart on Global Market Characteristics
  • Executive Summary - Chart on Market By Geographical Landscape
  • Executive Summary - Chart on Market Segmentation by Application
  • Executive Summary - Chart on Market Segmentation by Technology
  • Executive Summary - Chart on Incremental Growth
  • Executive Summary - Data Table on Incremental Growth
  • Executive Summary - Chart on Company Market Positioning

2 Market Landscape

• 2.1 Market ecosystem
  • Parent Market
  • Data Table on - Parent Market
• 2.2 Market characteristics
  • Market characteristics analysis
• 2.3 Value chain analysis
  • Value Chain Analysis

3 Market Sizing

• 3.1 Market definition
  • Offerings of companies included in the market definition
• 3.2 Market segment analysis
  • Market segments
• 3.3 Market size 2023
• 3.4 Market outlook: Forecast for 2023-2028
  • Chart on Global - Market size and forecast 2023-2028 ($ million)
  • Data Table on Global - Market size and forecast 2023-2028 ($ million)
  • Chart on Global Market: Year-over-year growth 2023-2028 (%)
  • Data Table on Global Market: Year-over-year growth 2023-2028 (%)

4 Historic Market Size

• 4.1 Global Liquid Biopsy Market 2018 - 2022
  • Historic Market Size - Data Table on Global Liquid Biopsy Market 2018 - 2022 ($ million)
• 4.2 Application segment analysis 2018 - 2022
  • Historic Market Size - Application Segment 2018 - 2022 ($ million)
• 4.3 Technology segment analysis 2018 - 2022
  • Historic Market Size - Technology Segment 2018 - 2022 ($ million)
• 4.4 Geography segment analysis 2018 - 2022
  • Historic Market Size - Geography Segment 2018 - 2022 ($ million)
• 4.5 Country segment analysis 2018 - 2022
  • Historic Market Size - Country Segment 2018 - 2022 ($ million)

5 Five Forces Analysis

• 5.1 Five forces summary
  • Five forces analysis - Comparison between 2023 and 2028
• 5.2 Bargaining power of buyers
  • Bargaining power of buyers - Impact of key factors 2023 and 2028
• 5.3 Bargaining power of suppliers
  • Bargaining power of suppliers - Impact of key factors in 2023 and 2028
• 5.4 Threat of new entrants
  • Threat of new entrants - Impact of key factors in 2023 and 2028
• 5.5 Threat of substitutes
  • Threat of substitutes - Impact of key factors in 2023 and 2028
• 5.6 Threat of rivalry
  • Threat of rivalry - Impact of key factors in 2023 and 2028
• 5.7 Market condition
  • Chart on Market condition - Five forces 2023 and 2028

6 Market Segmentation by Application

• 6.1 Market segments
  • Chart on Application - Market share 2023-2028 (%)
  • Data Table on Application - Market share 2023-2028 (%)
• 6.2 Comparison by Application
  • Chart on Comparison by Application
  • Data Table on Comparison by Application
• 6.3 Cancer applications - Market size and forecast 2023-2028
  • Chart on Cancer applications - Market size and forecast 2023-2028 ($ million)
  • Data Table on Cancer applications - Market size and forecast 2023-2028 ($ million)
  • Chart on Cancer applications - Year-over-year growth 2023-2028 (%)
  • Data Table on Cancer applications - Year-over-year growth 2023-2028 (%)
• 6.4 Non-cancer applications - Market size and forecast 2023-2028
  • Chart on Non-cancer applications - Market size and forecast 2023-2028 ($ million)
  • Data Table on Non-cancer applications - Market size and forecast 2023-2028 ($ million)
  • Chart on Non-cancer applications - Year-over-year growth 2023-2028 (%)
  • Data Table on Non-cancer applications - Year-over-year growth 2023-2028 (%)
• 6.5 Market opportunity by Application
  • Market opportunity by Application ($ million)
  • Data Table on Market opportunity by Application ($ million)

7 Market Segmentation by Technology

• 7.1 Market segments
  • Chart on Technology - Market share 2023-2028 (%)
  • Data Table on Technology - Market share 2023-2028 (%)
• 7.2 Comparison by Technology
  • Chart on Comparison by Technology
  • Data Table on Comparison by Technology
• 7.3 CTC and ctDNA - Market size and forecast 2023-2028
  • Chart on CTC and ctDNA - Market size and forecast 2023-2028 ($ million)
  • Data Table on CTC and ctDNA - Market size and forecast 2023-2028 ($ million)
  • Chart on CTC and ctDNA - Year-over-year growth 2023-2028 (%)
  • Data Table on CTC and ctDNA - Year-over-year growth 2023-2028 (%)
• 7.4 Exosome and RNA - Market size and forecast 2023-2028
  • Chart on Exosome and RNA - Market size and forecast 2023-2028 ($ million)
  • Data Table on Exosome and RNA - Market size and forecast 2023-2028 ($ million)
  • Chart on Exosome and RNA - Year-over-year growth 2023-2028 (%)
  • Data Table on Exosome and RNA - Year-over-year growth 2023-2028 (%)
• 7.5 Market opportunity by Technology
  • Market opportunity by Technology ($ million)
  • Data Table on Market opportunity by Technology ($ million)

8 Customer Landscape

• 8.1 Customer landscape overview
  • Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

9 Geographic Landscape

• 9.1 Geographic segmentation
  • Chart on Market share By Geographical Landscape 2023-2028 (%)
  • Data Table on Market share By Geographical Landscape 2023-2028 (%)
• 9.2 Geographic comparison
  • Chart on Geographic comparison
  • Data Table on Geographic comparison
• 9.3 North America - Market size and forecast 2023-2028
  • Chart on North America - Market size and forecast 2023-2028 ($ million)
  • Data Table on North America - Market size and forecast 2023-2028 ($ million)
  • Chart on North America - Year-over-year growth 2023-2028 (%)
  • Data Table on North America - Year-over-year growth 2023-2028 (%)
• 9.4 Europe - Market size and forecast 2023-2028
  • Chart on Europe - Market size and forecast 2023-2028 ($ million)
  • Data Table on Europe - Market size and forecast 2023-2028 ($ million)
  • Chart on Europe - Year-over-year growth 2023-2028 (%)
  • Data Table on Europe - Year-over-year growth 2023-2028 (%)
• 9.5 Asia - Market size and forecast 2023-2028
  • Chart on Asia - Market size and forecast 2023-2028 ($ million)
  • Data Table on Asia - Market size and forecast 2023-2028 ($ million)
  • Chart on Asia - Year-over-year growth 2023-2028 (%)
  • Data Table on Asia - Year-over-year growth 2023-2028 (%)
• 9.6 Rest of World (ROW) - Market size and forecast 2023-2028
  • Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
  • Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
  • Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
  • Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
• 9.7 US - Market size and forecast 2023-2028
  • Chart on US - Market size and forecast 2023-2028 ($ million)
  • Data Table on US - Market size and forecast 2023-2028 ($ million)
  • Chart on US - Year-over-year growth 2023-2028 (%)
  • Data Table on US - Year-over-year growth 2023-2028 (%)
• 9.8 Canada - Market size and forecast 2023-2028
  • Chart on Canada - Market size and forecast 2023-2028 ($ million)
  • Data Table on Canada - Market size and forecast 2023-2028 ($ million)
  • Chart on Canada - Year-over-year growth 2023-2028 (%)
  • Data Table on Canada - Year-over-year growth 2023-2028 (%)
• 9.9 Germany - Market size and forecast 2023-2028
  • Chart on Germany - Market size and forecast 2023-2028 ($ million)
  • Data Table on Germany - Market size and forecast 2023-2028 ($ million)
  • Chart on Germany - Year-over-year growth 2023-2028 (%)
  • Data Table on Germany - Year-over-year growth 2023-2028 (%)
• 9.10 UK - Market size and forecast 2023-2028
  • Chart on UK - Market size and forecast 2023-2028 ($ million)
  • Data Table on UK - Market size and forecast 2023-2028 ($ million)
  • Chart on UK - Year-over-year growth 2023-2028 (%)
  • Data Table on UK - Year-over-year growth 2023-2028 (%)
• 9.11 Japan - Market size and forecast 2023-2028
  • Chart on Japan - Market size and forecast 2023-2028 ($ million)
  • Data Table on Japan - Market size and forecast 2023-2028 ($ million)
  • Chart on Japan - Year-over-year growth 2023-2028 (%)
  • Data Table on Japan - Year-over-year growth 2023-2028 (%)
• 9.12 Market opportunity By Geographical Landscape
  • Market opportunity By Geographical Landscape ($ million)
  • Data Tables on Market opportunity By Geographical Landscape ($ million)

10 Drivers, Challenges, and Opportunity/Restraints

• 10.1 Market drivers
• 10.2 Market challenges
• 10.3 Impact of drivers and challenges
  • Impact of drivers and challenges in 2023 and 2028
• 10.4 Market opportunities/restraints

11 Competitive Landscape

• 11.1 Overview
• 11.2 Competitive Landscape
  • Overview on criticality of inputs and factors of differentiation
• 11.3 Landscape disruption
  • Overview on factors of disruption
• 11.4 Industry risks
  • Impact of key risks on business

12 Competitive Analysis

• 12.1 Companies profiled
  • Companies covered
• 12.2 Market positioning of companies
  • Matrix on companies position and classification
• 12.3 A. Menarini Industrie Farmaceutiche Riunite Srl
  • A. Menarini Industrie Farmaceutiche Riunite Srl - Overview
  • A. Menarini Industrie Farmaceutiche Riunite Srl - Product / Service
  • A. Menarini Industrie Farmaceutiche Riunite Srl - Key offerings
• 12.4 ANGLE Plc
  • ANGLE Plc - Overview
  • ANGLE Plc - Product / Service
  • ANGLE Plc - Key offerings
• 12.5 Bio Techne Corp.
  • Bio Techne Corp. - Overview
  • Bio Techne Corp. - Business segments
  • Bio Techne Corp. - Key news
  • Bio Techne Corp. - Key offerings
  • Bio Techne Corp. - Segment focus
• 12.6 Biocept Inc.
  • Biocept Inc. - Overview
  • Biocept Inc. - Product / Service
  • Biocept Inc. - Key offerings
• 12.7 Biodesix Inc.
  • Biodesix Inc. - Overview
  • Biodesix Inc. - Product / Service
  • Biodesix Inc. - Key offerings
• 12.8 CellMax Inc.
  • CellMax Inc. - Overview
  • CellMax Inc. - Product / Service
  • CellMax Inc. - Key offerings
• 12.9 CIRCULOGENE
  • CIRCULOGENE - Overview
  • CIRCULOGENE - Product / Service
  • CIRCULOGENE - Key offerings
• 12.10 Exact Sciences Corp.
  • Exact Sciences Corp. - Overview
  • Exact Sciences Corp. - Product / Service
  • Exact Sciences Corp. - Key news
  • Exact Sciences Corp. - Key offerings
• 12.11 F. Hoffmann La Roche Ltd.
  • F. Hoffmann La Roche Ltd. - Overview
  • F. Hoffmann La Roche Ltd. - Business segments
  • F. Hoffmann La Roche Ltd. - Key news
  • F. Hoffmann La Roche Ltd. - Key offerings
  • F. Hoffmann La Roche Ltd. - Segment focus
• 12.12 Guardant Health Inc.
  • Guardant Health Inc. - Overview
  • Guardant Health Inc. - Product / Service
  • Guardant Health Inc. - Key news
  • Guardant Health Inc. - Key offerings
• 12.13 Illumina Inc.
  • Illumina Inc. - Overview
  • Illumina Inc. - Business segments
  • Illumina Inc. - Key news
  • Illumina Inc. - Key offerings
  • Illumina Inc. - Segment focus
• 12.14 MDXHEALTH SA
  • MDXHEALTH SA - Overview
  • MDXHEALTH SA - Product / Service
  • MDXHEALTH SA - Key offerings
• 12.15 Myriad Genetics Inc.
  • Myriad Genetics Inc. - Overview
  • Myriad Genetics Inc. - Product / Service
  • Myriad Genetics Inc. - Key news
  • Myriad Genetics Inc. - Key offerings
• 12.16 QIAGEN NV
  • QIAGEN NV - Overview
  • QIAGEN NV - Product / Service
  • QIAGEN NV - Key news
  • QIAGEN NV - Key offerings
• 12.17 SAGA Diagnostics AB
  • SAGA Diagnostics AB - Overview
  • SAGA Diagnostics AB - Product / Service
  • SAGA Diagnostics AB - Key offerings

13 Appendix

• 13.1 Scope of the report
• 13.2 Inclusions and exclusions checklist
  • Inclusions checklist
  • Exclusions checklist
• 13.3 Currency conversion rates for US$
  • Currency conversion rates for US$
• 13.4 Research methodology
  • Research methodology
• 13.5 Data procurement
  • Information sources
• 13.6 Data validation
  • Data validation
• 13.7 Validation techniques employed for market sizing
  • Validation techniques employed for market sizing
• 13.8 Data synthesis
  • Data synthesis
• 13.9 360 degree market analysis
  • 360 degree market analysis
• 13.10 List of abbreviations
  • List of abbreviations

Exhibits:

• Exhibits1: Executive Summary - Chart on Market Overview
• Exhibits2: Executive Summary - Data Table on Market Overview
• Exhibits3: Executive Summary - Chart on Global Market Characteristics
• Exhibits4: Executive Summary - Chart on Market By Geographical Landscape
• Exhibits5: Executive Summary - Chart on Market Segmentation by Application
• Exhibits6: Executive Summary - Chart on Market Segmentation by Technology
• Exhibits7: Executive Summary - Chart on Incremental Growth
• Exhibits8: Executive Summary - Data Table on Incremental Growth
• Exhibits9: Executive Summary - Chart on Company Market Positioning
• Exhibits10: Parent Market
• Exhibits11: Data Table on - Parent Market
• Exhibits12: Market characteristics analysis
• Exhibits13: Value Chain Analysis
• Exhibits14: Offerings of companies included in the market definition
• Exhibits15: Market segments
• Exhibits16: Chart on Global - Market size and forecast 2023-2028 ($ million)
• Exhibits17: Data Table on Global - Market size and forecast 2023-2028 ($ million)
• Exhibits18: Chart on Global Market: Year-over-year growth 2023-2028 (%)
• Exhibits19: Data Table on Global Market: Year-over-year growth 2023-2028 (%)
• Exhibits20: Historic Market Size - Data Table on Global Liquid Biopsy Market 2018 - 2022 ($ million)
• Exhibits21: Historic Market Size - Application Segment 2018 - 2022 ($ million)
• Exhibits22: Historic Market Size - Technology Segment 2018 - 2022 ($ million)
• Exhibits23: Historic Market Size - Geography Segment 2018 - 2022 ($ million)
• Exhibits24: Historic Market Size - Country Segment 2018 - 2022 ($ million)
• Exhibits25: Five forces analysis - Comparison between 2023 and 2028
• Exhibits26: Bargaining power of buyers - Impact of key factors 2023 and 2028
• Exhibits27: Bargaining power of suppliers - Impact of key factors in 2023 and 2028
• Exhibits28: Threat of new entrants - Impact of key factors in 2023 and 2028
• Exhibits29: Threat of substitutes - Impact of key factors in 2023 and 2028
• Exhibits30: Threat of rivalry - Impact of key factors in 2023 and 2028
• Exhibits31: Chart on Market condition - Five forces 2023 and 2028
• Exhibits32: Chart on Application - Market share 2023-2028 (%)
• Exhibits33: Data Table on Application - Market share 2023-2028 (%)
• Exhibits34: Chart on Comparison by Application
• Exhibits35: Data Table on Comparison by Application
• Exhibits36: Chart on Cancer applications - Market size and forecast 2023-2028 ($ million)
• Exhibits37: Data Table on Cancer applications - Market size and forecast 2023-2028 ($ million)
• Exhibits38: Chart on Cancer applications - Year-over-year growth 2023-2028 (%)
• Exhibits39: Data Table on Cancer applications - Year-over-year growth 2023-2028 (%)
• Exhibits40: Chart on Non-cancer applications - Market size and forecast 2023-2028 ($ million)
• Exhibits41: Data Table on Non-cancer applications - Market size and forecast 2023-2028 ($ million)
• Exhibits42: Chart on Non-cancer applications - Year-over-year growth 2023-2028 (%)
• Exhibits43: Data Table on Non-cancer applications - Year-over-year growth 2023-2028 (%)
• Exhibits44: Market opportunity by Application ($ million)
• Exhibits45: Data Table on Market opportunity by Application ($ million)
• Exhibits46: Chart on Technology - Market share 2023-2028 (%)
• Exhibits47: Data Table on Technology - Market share 2023-2028 (%)
• Exhibits48: Chart on Comparison by Technology
• Exhibits49: Data Table on Comparison by Technology
• Exhibits50: Chart on CTC and ctDNA - Market size and forecast 2023-2028 ($ million)
• Exhibits51: Data Table on CTC and ctDNA - Market size and forecast 2023-2028 ($ million)
• Exhibits52: Chart on CTC and ctDNA - Year-over-year growth 2023-2028 (%)
• Exhibits53: Data Table on CTC and ctDNA - Year-over-year growth 2023-2028 (%)
• Exhibits54: Chart on Exosome and RNA - Market size and forecast 2023-2028 ($ million)
• Exhibits55: Data Table on Exosome and RNA - Market size and forecast 2023-2028 ($ million)
• Exhibits56: Chart on Exosome and RNA - Year-over-year growth 2023-2028 (%)
• Exhibits57: Data Table on Exosome and RNA - Year-over-year growth 2023-2028 (%)
• Exhibits58: Market opportunity by Technology ($ million)
• Exhibits59: Data Table on Market opportunity by Technology ($ million)
• Exhibits60: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
• Exhibits61: Chart on Market share By Geographical Landscape 2023-2028 (%)
• Exhibits62: Data Table on Market share By Geographical Landscape 2023-2028 (%)
• Exhibits63: Chart on Geographic comparison
• Exhibits64: Data Table on Geographic comparison
• Exhibits65: Chart on North America - Market size and forecast 2023-2028 ($ million)
• Exhibits66: Data Table on North America - Market size and forecast 2023-2028 ($ million)
• Exhibits67: Chart on North America - Year-over-year growth 2023-2028 (%)
• Exhibits68: Data Table on North America - Year-over-year growth 2023-2028 (%)
• Exhibits69: Chart on Europe - Market size and forecast 2023-2028 ($ million)
• Exhibits70: Data Table on Europe - Market size and forecast 2023-2028 ($ million)
• Exhibits71: Chart on Europe - Year-over-year growth 2023-2028 (%)
• Exhibits72: Data Table on Europe - Year-over-year growth 2023-2028 (%)
• Exhibits73: Chart on Asia - Market size and forecast 2023-2028 ($ million)
• Exhibits74: Data Table on Asia - Market size and forecast 2023-2028 ($ million)
• Exhibits75: Chart on Asia - Year-over-year growth 2023-2028 (%)
• Exhibits76: Data Table on Asia - Year-over-year growth 2023-2028 (%)
• Exhibits77: Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
• Exhibits78: Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
• Exhibits79: Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
• Exhibits80: Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
• Exhibits81: Chart on US - Market size and forecast 2023-2028 ($ million)
• Exhibits82: Data Table on US - Market size and forecast 2023-2028 ($ million)
• Exhibits83: Chart on US - Year-over-year growth 2023-2028 (%)
• Exhibits84: Data Table on US - Year-over-year growth 2023-2028 (%)
• Exhibits85: Chart on Canada - Market size and forecast 2023-2028 ($ million)
• Exhibits86: Data Table on Canada - Market size and forecast 2023-2028 ($ million)
• Exhibits87: Chart on Canada - Year-over-year growth 2023-2028 (%)
• Exhibits88: Data Table on Canada - Year-over-year growth 2023-2028 (%)
• Exhibits89: Chart on Germany - Market size and forecast 2023-2028 ($ million)
• Exhibits90: Data Table on Germany - Market size and forecast 2023-2028 ($ million)
• Exhibits91: Chart on Germany - Year-over-year growth 2023-2028 (%)
• Exhibits92: Data Table on Germany - Year-over-year growth 2023-2028 (%)
• Exhibits93: Chart on UK - Market size and forecast 2023-2028 ($ million)
• Exhibits94: Data Table on UK - Market size and forecast 2023-2028 ($ million)
• Exhibits95: Chart on UK - Year-over-year growth 2023-2028 (%)
• Exhibits96: Data Table on UK - Year-over-year growth 2023-2028 (%)
• Exhibits97: Chart on Japan - Market size and forecast 2023-2028 ($ million)
• Exhibits98: Data Table on Japan - Market size and forecast 2023-2028 ($ million)
• Exhibits99: Chart on Japan - Year-over-year growth 2023-2028 (%)
• Exhibits100: Data Table on Japan - Year-over-year growth 2023-2028 (%)
• Exhibits101: Market opportunity By Geographical Landscape ($ million)
• Exhibits102: Data Tables on Market opportunity By Geographical Landscape ($ million)
• Exhibits103: Impact of drivers and challenges in 2023 and 2028
• Exhibits104: Overview on criticality of inputs and factors of differentiation
• Exhibits105: Overview on factors of disruption
• Exhibits106: Impact of key risks on business
• Exhibits107: Companies covered
• Exhibits108: Matrix on companies position and classification
• Exhibits109: A. Menarini Industrie Farmaceutiche Riunite Srl - Overview
• Exhibits110: A. Menarini Industrie Farmaceutiche Riunite Srl - Product / Service
• Exhibits111: A. Menarini Industrie Farmaceutiche Riunite Srl - Key offerings
• Exhibits112: ANGLE Plc - Overview
• Exhibits113: ANGLE Plc - Product / Service
• Exhibits114: ANGLE Plc - Key offerings
• Exhibits115: Bio Techne Corp. - Overview
• Exhibits116: Bio Techne Corp. - Business segments
• Exhibits117: Bio Techne Corp. - Key news
• Exhibits118: Bio Techne Corp. - Key offerings
• Exhibits119: Bio Techne Corp. - Segment focus
• Exhibits120: Biocept Inc. - Overview
• Exhibits121: Biocept Inc. - Product / Service
• Exhibits122: Biocept Inc. - Key offerings
• Exhibits123: Biodesix Inc. - Overview
• Exhibits124: Biodesix Inc. - Product / Service
• Exhibits125: Biodesix Inc. - Key offerings
• Exhibits126: CellMax Inc. - Overview
• Exhibits127: CellMax Inc. - Product / Service
• Exhibits128: CellMax Inc. - Key offerings
• Exhibits129: CIRCULOGENE - Overview
• Exhibits130: CIRCULOGENE - Product / Service
• Exhibits131: CIRCULOGENE - Key offerings
• Exhibits132: Exact Sciences Corp. - Overview
• Exhibits133: Exact Sciences Corp. - Product / Service
• Exhibits134: Exact Sciences Corp. - Key news
• Exhibits135: Exact Sciences Corp. - Key offerings
• Exhibits136: F. Hoffmann La Roche Ltd. - Overview
• Exhibits137: F. Hoffmann La Roche Ltd. - Business segments
• Exhibits138: F. Hoffmann La Roche Ltd. - Key news
• Exhibits139: F. Hoffmann La Roche Ltd. - Key offerings
• Exhibits140: F. Hoffmann La Roche Ltd. - Segment focus
• Exhibits141: Guardant Health Inc. - Overview
• Exhibits142: Guardant Health Inc. - Product / Service
• Exhibits143: Guardant Health Inc. - Key news
• Exhibits144: Guardant Health Inc. - Key offerings
• Exhibits145: Illumina Inc. - Overview
• Exhibits146: Illumina Inc. - Business segments
• Exhibits147: Illumina Inc. - Key news
• Exhibits148: Illumina Inc. - Key offerings
• Exhibits149: Illumina Inc. - Segment focus
• Exhibits150: MDXHEALTH SA - Overview
• Exhibits151: MDXHEALTH SA - Product / Service
• Exhibits152: MDXHEALTH SA - Key offerings
• Exhibits153: Myriad Genetics Inc. - Overview
• Exhibits154: Myriad Genetics Inc. - Product / Service
• Exhibits155: Myriad Genetics Inc. - Key news
• Exhibits156: Myriad Genetics Inc. - Key offerings
• Exhibits157: QIAGEN NV - Overview
• Exhibits158: QIAGEN NV - Product / Service
• Exhibits159: QIAGEN NV - Key news
• Exhibits160: QIAGEN NV - Key offerings
• Exhibits161: SAGA Diagnostics AB - Overview
• Exhibits162: SAGA Diagnostics AB - Product / Service
• Exhibits163: SAGA Diagnostics AB - Key offerings
• Exhibits164: Inclusions checklist
• Exhibits165: Exclusions checklist
• Exhibits166: Currency conversion rates for US$
• Exhibits167: Research methodology
• Exhibits168: Information sources
• Exhibits169: Data validation
• Exhibits170: Validation techniques employed for market sizing
• Exhibits171: Data synthesis
• Exhibits172: 360 degree market analysis
• Exhibits173: List of abbreviations